The Global Influenza Market - new market research report published

companiesandmarkets.com

2012-11-30 09:40:32 - The Global Influenza Market - a new market research report on companiesandmarkets.com

- Overall sales in the global influenza market were worth $5.3 billion in 2007, which declined to $3.7 billion in 2008, then increased to an estimated $5.5 billion in 2009. By 2014, it is projected to increase to $6.3 billion, for a 5-year CAGR of 2.7%.- The largest segment of the market, vaccines, was valued at $2.8 billion in 2008;

 

 

this is expected to increase to $3.2 billion in 2009, and is projected to reach $4.2 billion in 2014, for a 5-year CAGR of 5.6%.- Sales in the therapeutics market amounted to $701 million in 2008, increased to an estimated $2.1 billion in 2009, and are expected to fall to $1.9 billion in 2014, for a 5-year CAGR of -2.4%.
This report provides an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments. The study includes information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers. There is a special emphasis on U.S. and European markets.REASONS FOR DOING THE STUDY

Annually, up to a half-million people die of influenza and, with the threat of a pandemic, government agencies and disease prevention organizations are devoted to gaining control of the situation. Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies.The next 5 years will continue to display support and funding for many research and development programs, product development and pandemic prevention and/or control by worldwide governments, organizations, and health professionals.

SCOPE OF REPORT

This report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. data.The report identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts, and competitive analyses. Additionally, the study covers some of the most significant issues and trends and market factors.&

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.